Biopharma Suzhou Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biopharma suzhou inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biopharma Suzhou Inc Today - Breaking & Trending Today

CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein

Share this article
SUZHOU, China, March 7, 2021 /PRNewswire/ Recently,
CMAB Biopharma (Suzhou) Inc s ( CMAB ) partner Shanghai Junshi Biosciences Co., Ltd. ( Junshi Biosciences ) (HK: 1877; SH: 688180), announced that a clinical trial application for its PD-1/TGF-β bifunctional fusion protein JS201 injection (JS201) has been accepted by National Medical Products Administration (NMPA).
JS201 is a bifunctional fusion protein developed by Junshi using its proprietary technology that can simultaneously target PD-1 and TGF-β (transforming growth factor-β). JS201 is the first product targeting PD-1/TGF-β approved for a clinical trial application in China. JS201 can effectively block the immunosuppressive pathways of PD-1 and TGF-β which improves the immunomodulatory effect in the tumor microenvironment, thereby promoting the killing effect of the patient s immune system on tumor cells and reducing the occurrence of immune escape and drug resistance. ....

United States , San Francisco , Junshi Biosciences , Yongzhong Wang , Eli Lilly , Institute Of Microbiology Chinese Academy Science , Biopharma Suzhou Inc , National Medical Products Administration , Shanghai Junshi Biosciences Co Ltd , Microbiology Chinese Academy , Qualified Person , Cmab Biopharma Suzhou Inc , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , எலி லில்லி , நிறுவனம் ஆஃப் நுண்ணுயிரியல் சீன கலைக்கழகம் அறிவியல் , நுண்ணுயிரியல் சீன கலைக்கழகம் , தகுதி நபர் ,

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Yongzhong Wang , Biopharma Suzhou Inc , Drug Administration , Innovent Biologics Inc , Innovent Biologics , Investigational New Drug , Suzhou Industrial , சூழோ தொழில்துறை ,

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Yongzhong Wang , Biopharma Suzhou Inc , Drug Administration , Innovent Biologics Inc , Innovent Biologics , Investigational New Drug , Suzhou Industrial , சூழோ தொழில்துறை ,